Recent studies reveal engineered suppressor tRNAs can overcome premature stop codons, restoring protein function in genetic disorders. Innovations from companies like Alltrna and Tevard, utilizing lipid nanoparticle delivery, mirror breakthroughs in mRNA vaccines. This promising therapy may pave the way for advanced treatments targeting liver and other tissues.